Melanoma
Melanoma tumor growth and metastasis inhibited by GPR56
Published in Gene Therapy Weekly, August 24th, 2006
"The survival and growth of tumor cells in a foreign environment is considered a rate-limiting step during metastasis. To identify genes that may be essential for this process, we isolated highly metastatic variants from a poorly metastatic human melanoma cell line and performed expression analyses of metastases and primary tumors from these cells," scientists in the United States reported.
"GPR56 is among the genes markedly down-regulated in the metastatic variants. We show that overexpression of GPR56...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-08-24)
More Articles from Gene Therapy Weekly
- Cancer Gene Therapy
Proliferation of esophageal cancer cells promoted by differentiation inhibitor - Cancer Therapy
Ganglioside modulates tumor suppressor-mediated transcriptional induction - Glioblastoma
Telomerase inhibition impairs tumor growth in glioblastoma xenografts - Hepatitis B Virus
Hepatitis B virus replication is efficiently inhibited by small interfering RNAs - Ophthalmology
Effects of retrotransposon insertion on photoreceptor transcription clarified - Allergy & Immunology
Aspergillus-sensitized early airway response inhibited by a surfactant protein - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
